ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,236Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 551

$912K Total Retail Price of All Prescriptions

Rank: 23 out of 551

722 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 722 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 17,378 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
PRAVASTATIN SODIUM 1,123 900 1 24
RANITIDINE HCL 812 617 2 8
OMEPRAZOLE 571 482 3 7
FENOFIBRATE 561 434 4 34
CLOPIDOGREL 519 447 5 30
ENALAPRIL MALEATE 513 393 6 5
SYNTHROID 492 380 7 11
GABAPENTIN 476 367 8 3
LOSARTAN POTASSIUM 471 401 9 6
AMLODIPINE BESYLATE 447 338 10 4
LEVOTHYROXINE SODIUM 437 358 11 9
LOSARTAN-HYDROCHLOROTHIAZIDE 417 313 12 10
PANTOPRAZOLE SODIUM 405 357 13 36
METFORMIN HCL 402 288 14 2
HYDROCHLOROTHIAZIDE 389 311 15 15
FUROSEMIDE 361 246 16 13
PLAVIX 346 296 17 33
ISOSORBIDE MONONITRATE ER 321 279 18 21
SIMVASTATIN 304 253 19 1
CILOSTAZOL 302 249 20 64
ATENOLOL 288 223 21 12
GLYBURIDE-METFORMIN HCL 280 198 R 22 48
FINASTERIDE 260 238 23 82
TAMSULOSIN HCL 258 213 24 38
ASPIRIN EC 252 210 25 26
METOPROLOL TARTRATE 243 220 26 17
GLIMEPIRIDE 218 175 27 16
METOPROLOL SUCCINATE 208 154 28 23
ATORVASTATIN CALCIUM 202 156 29 29
PREDNISOLONE 198 157 10 30 118
NAMENDA 192 191 31 94
GLIPIZIDE 187 134 32 20
DOXAZOSIN MESYLATE 185 142 33 25
FAMOTIDINE 174 145 34 31
LEVOFLOXACIN 173 133 35 117
MAXIMUM D3 167 132 36 103
CARVEDILOL 164 118 37 22
DICLOFENAC POTASSIUM 158 122 38 45
LANTUS 155 102 39 28
ZOLPIDEM TARTRATE 155 106 39 27
CLARITHROMYCIN 151 105 10 41 239
LISINOPRIL 150 122 42 14
AMOX TR-POTASSIUM CLAVULANATE 149 107 43 113
WARFARIN SODIUM 149 148 43 46
DONEPEZIL HCL 141 140 45 50
LANSOPRAZOLE 139 90 46 72
DIOVAN HCT 132 93 47 71
PENTOXIFYLLINE 128 99 48 73
HUMULIN N 127 102 49 47
IRBESARTAN 126 97 50 51
DIOVAN 125 102 51 57
INSULIN SYRINGE 125 76 51 41
GLIPIZIDE ER 119 100 53 85
TRAMADOL HCL 119 92 53 32
MECLIZINE HCL 113 96 55 56
HUMULIN 70-30 111 100 56 35
NABUMETONE 109 61 57 37
DIGOXIN 109 103 57 44
CRESTOR 107 76 59 62
TRICOR 107 88 59 126
MELOXICAM 100 85 61 90
CIPROFLOXACIN HCL 94 75 62 54
ZETIA 94 79 62 69
SPIRONOLACTONE 93 86 64 79
GLIPIZIDE XL 87 85 65 81
CARAFATE 86 67 66 130
CLONIDINE HCL 82 44 67 60
ORPHENADRINE CITRATE 81 54 R 68 147
FLUCONAZOLE 81 53 68 169
JANUVIA 80 44 70 87
AMLODIPINE BESYLATE-BENAZEPRIL 79 56 71 42
NAPROXEN 77 48 72 80
CEFTRIAXONE 76 58 73 310
EXELON 76 76 73 201
PROPRANOLOL HCL 73 73 75 139
THEOPHYLLINE ANHYDROUS 72 58 76 125
HUMALOG MIX 75-25 71 30 77 110
VERAPAMIL ER 71 54 77 39
COUMADIN 68 63 79 88
AVAPRO 68 46 79 83
SINGULAIR 66 49 81 58
SERTRALINE HCL 65 55 82 43
CALTRATE 600+D PLUS 61 54 10 83 341
DESONIDE 60 40 84 233
PROVENTIL HFA 58 50 85 176
TRAMADOL HCL-ACETAMINOPHEN 58 50 85 18
ONGLYZA 52 25 87 145
CAPTOPRIL 52 45 87 63
NIFEDIPINE ER 50 21 89 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.